HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and TGF-β in renovascular hypertension-induced cardiac hypertrophy.

Abstract
Cardiovascular remodeling found in later phases of two-kidney, one-clip (2K1C) hypertension may involve key mechanisms particularly including MMP-2, oxidative stress, transforming growth factor-β (TGF-β), and inactivation of the endogenous MMP inhibitor, the tissue inhibitor of MMP (TIMP)-4. We examined whether temporal cardiac remodeling resulting from 2K1C hypertension occurs concomitantly with alterations in cardiac collagen, MMP activity, MMP-2, TIMP-4, TGF-β, and reactive oxygen species (ROS) levels during the development of 2K1C hypertension. Sham-operated and 2K1C hypertensive rats were studied after 15, 30, and 75 days of hypertension. Systolic blood pressure was monitored weekly. Left ventricle (LV) morphometry and fibrosis were evaluated in hematoxylin/eosin and picrosirius red-stained sections, respectively. Cardiac MMP-2 levels/activity was determined by gelatin zymography, immunofluorescence, and in situ zymography. TIMP-4 levels were determined by western blotting. Cardiac TGF-β levels were evaluated by immunofluorescence and ROS levels were evaluated with a dihydroethidium probe. 2K1C hypertension induced LV hypertrophy associated with augmented gelatinolytic activity at an early phase of hypertension and further increased after 75 days of hypertension. These alterations were associated with increased cardiac MMP-2, TGF-β, and ROS in hypertensive rats. Higher TIMP-4 levels were found in hypertensive rats only after 75 days after surgery. Our findings show that increased MMP-2 activity is associated with concomitant development of LV hypertrophy and increased TGF-β and ROS levels.
AuthorsElen Rizzi, Carla S Ceron, Danielle A Guimaraes, Cibele M Prado, Marcos A Rossi, Raquel F Gerlach, Jose E Tanus-Santos
JournalExperimental and molecular pathology (Exp Mol Pathol) Vol. 94 Issue 1 Pg. 1-9 (Feb 2013) ISSN: 1096-0945 [Electronic] United States
PMID23073243 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 Elsevier Inc. All rights reserved.
Chemical References
  • Reactive Oxygen Species
  • Tissue Inhibitor of Metalloproteinases
  • Transforming Growth Factor beta
  • tissue inhibitor of metalloproteinase-4
  • Collagen
  • Matrix Metalloproteinase 2
Topics
  • Animals
  • Blood Pressure
  • Cardiomegaly (etiology, metabolism, pathology)
  • Collagen (metabolism)
  • Fibrosis
  • Heart (physiopathology)
  • Heart Ventricles
  • Hypertension, Renovascular (complications, metabolism)
  • Male
  • Matrix Metalloproteinase 2 (metabolism)
  • Myocardium (metabolism, pathology)
  • Oxidative Stress
  • Rats
  • Rats, Wistar
  • Reactive Oxygen Species (metabolism)
  • Tissue Inhibitor of Metalloproteinases (metabolism)
  • Transforming Growth Factor beta (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: